Does normal substantia nigra echogenicity make a difference in Parkinson’s disease diagnosis? A real clinical practice follow-up study

Objectives Substantia nigra hyperechogenicity (SN+) detected by transcranial ultrasound (TUS) is useful for Parkinson’s disease (PD) diagnosis. Approximately 15% false negative results of unknown significance are reported. However, most TUS studies are transversal, and diagnosis of PD may change dur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurology 2018-10, Vol.265 (10), p.2363-2369
Hauptverfasser: Alonso-Canovas, Araceli, Lopez-Sendon Moreno, Jose Luis, Buisan, Javier, Sainz de la Maza, Susana, Costa-Frossard, Lucienne, Garcia-Ribas, Guillermo, de Felipe-Mimbrera, Alicia, Matute-Lozano, Maria Consuelo, Zarza Sanz, Beatriz, Toledano Delgado, Rafael, Corral, Iñigo, Masjuan, Jaime, Martinez-Castrillo, Juan Carlos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives Substantia nigra hyperechogenicity (SN+) detected by transcranial ultrasound (TUS) is useful for Parkinson’s disease (PD) diagnosis. Approximately 15% false negative results of unknown significance are reported. However, most TUS studies are transversal, and diagnosis of PD may change during follow-up. Methods Analysis of our prospective registry of TUS in clinical practice, selecting patients with sufficient bone window, to whom TUS was performed because of suspected PD, and a minimum of 3-year follow-up. Subjects were classified regarding SN echogenicity (SN+/SN−). Results 172 patients (122 SN+, 50 SN−), mean age 71 years (25–90), were included. At the end of follow-up, PD diagnosis was retained by 91% SN+ vs. 54% SN− subjects ( p  
ISSN:0340-5354
1432-1459
DOI:10.1007/s00415-018-9006-5